Johnson & Johnson

NYSE: JNJ
$148.15
+$1.12 (+0.8%)
Closing Price on January 21, 2025

JNJ Articles

Sony (NYSE: SNE) will sell its LCD business to Samsung for $940 million. (Reuters) The yuan hits a high against the dollar and may gain 4% this year. (Reuters) Amazon.com’s (NASDAQ: AMZN) program...
Throughout December we have been giving updates on dividends that will rise in the coming days and weeks from the 30 Dow Jones Industrial Average stocks. Many have already come true and others are...
Dividends are still rising and equity and income investors should expect more of the same for 2012. The Walt Disney Company (NYSE: DIS) joined in on the dividend hike brigade with another dividend...
It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1 billion to fail to get the drug to market. Like the movie business, a drug company tries to develop that...
The economic choppiness is coming to a head with the age of dividend hikes. The pressure is going to remain for companies to continue returning capital to shareholders while also looking for...
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of September 30, 2011. These public stock holdings have been broken...
Italy and Greece begin efforts to prove that their sovereign debt is safe. (Reuters) Groupon (NASDAQ: GRPN) will make a major holiday effort to drive extra revenue. (Reuters) Appetite for Olympus...
Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better than analysts expected, but worries persist that the company will be hit...
It’s that time of year again, when proxies are released and many business publications run lists of the highest paid CEOs at America’s large public companies. The compensation figures are...
Today was a day of red that went to a day of green.  Earnings were at first a disappointment, and producer price index came out far hotter at +0.8% on the headline number before the +0.2% reading if...
Earnings season is upon us and so far things are shaping up either a bit better, or less-bad, than what the news reports and headlines might have led investors to believe. Next week is going to be...
Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent new on the coming flu season, lower rates of prescription writing, and more...
With fears of a new economic downturn, investors have become concerned about sales and profits of large companies. But there are companies that have already proven themselves in the recent recession....
Angela Merkel faces a test: will her own party support money being used for the bailout of Greece? (Reuters) Bernanke says the Fed may have to act if inflation falls below targets. (Reuters)...
These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls. Amerisafe, Inc. (NASDAQ: AMSF) named Bear of the Day at...
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.